QQQ
-4.91
297.46
-1.68%
BTC/USD
-61.45
17047.45
-0.3592%
DIA
-4.60
349.34
-1.33%
SPY
-7.15
414.06
-1.76%
TLT
-1.50
108.59
-1.4%
GLD
-2.85
170.11
-1.7%

Cannabis News and Psychedelics News

CAMBIAR A ESPAÑOL

Find the top psychedelics and cannabis news on Benzinga. Everything you need to know in relation to stocks, business, finance, politics, policy, culture, and more.

* Ahora también tenemos noticias de cannabis en Español.

Today's Top Cannabis News

EXCLUSIVE: Medical Marijuana Patients In New Mexico Will Receive Workers' Compensation Benefits

EXCLUSIVE: Medical Marijuana Patients In New Mexico Will Receive Workers’ Compensation Benefits

Bennabis Health, a company that is helping to fill holes in the health insurance industry for medical marijuana patients has expanded into New Mexico. read more
Where To Buy Legal Weed These Days: Newest Marijuana Shops In FL & CA

Where To Buy Legal Weed These Days: Newest Marijuana Shops In FL & CA

MegaBud Opens Two More Cannabis Convenience Stores In CA read more
Aurora Cannabis Repurchases $76.1M Principal Amount Of Convertible Notes

Aurora Cannabis Repurchases $76.1M Principal Amount Of Convertible Notes

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) has repurchased an aggregate of approximately CA$102.5 million ($76.1 million) principal amount of its convertible senior notes at a total cost, including accrued interest, of CA$99.4 million ($73.8 million) in ca read more
Biden Signs Marijuana Research Bill Into Law, Historic Moment For Federal Cannabis Reform

Biden Signs Marijuana Research Bill Into Law, Historic Moment For Federal Cannabis Reform

President Joe Biden has officially signed a marijuana research bill into law, making history by enacting the first piece of standalone federal cannabis reform legislation in U.S. history, reported Marijuana Moment. read more
DEA Announces How Much Marijuana, MDMA, Psilocyn, LSD, Mescaline, 5-MeO-DMT, MDA, 2-CB Can Be Produced For Research In 2023

DEA Announces How Much Marijuana, MDMA, Psilocyn, LSD, Mescaline, 5-MeO-DMT, MDA, 2-CB Can Be Produced For Research In 2023

The DEA has shared its final production quotas for research drugs for 2023 and is now aiming for further manufacturing goals of several psychedelic compounds than the already substantial increases regarding 2022 initially proposed,  read more

Benzinga is an innovative financial news outlet that has become the first choice for brokerages given its easy-to-integrate API suite and easy-to-consume content. Benzinga provides timely, actionable news that helps users navigate a wide breadth of equities in even the most uncertain and volatile markets, in real time.

Since 2010, Benzinga has focused on delivering consistent, fast reporting on cannabis news, stocks, politics, and culture in the United States and the entire world. Our team features top talent in the industry, providing knowledgeable insights for investors and entrepreneurs.

Benzinga also hosts the most successful cannabis investing event in the world, the Benzinga Cannabis Capital Conference. The CCC will be returning to Miami on April 11 & 12 of 2023. You can secure your tickets now, at the lowest price you’ll ever find them. This is the place where deals get done, companies get funded, and business really happens.

The Benzinga Cannabis team is led by renowned cannabis journalist Javier Hasse. The news section is edited by long-time cannabis reporter Maureen Meehan and associate editor Nina Zdinjak. The team also features top talent in the space, including, but not limited to, Nicolás Jose Rodriguez, PhDc, Natán Ponieman, Jelena Martinovic, Vuk Zdinjak, Anthony Noto, Joana Scopel and Lara Goldstein.

In addition, Benzinga proudly supports ElPlanteo.com, the most-read cannabis-focused media outlet in all of the Spanish-speaking world.

Check out our content on a daily basis, as we deliver more than 30 articles on cannabis every day. We also offer a daily podcast, Cannabis Daily, hosted by Elliot Lane, and a bi-weekly video show and podcast, Cannabis Insider, co-hosted by Javier Hasse and Elliot Lane, and featuring the top public company executives and leading investors and policymakers in the cannabis space.